捷心隆(02115.HK)預期2020財年純利同比減少60%
格隆匯 2 月 10日丨捷心隆(02115.HK)公吿, 集團能夠於2020財政年度錄得相若收益。然而,監於(i)毛利率減少約4個百分點;及(ii)上市開支增加約人民幣500萬元,故集團預期2020財政年度的未經審核綜合純利將較截至2019年12月31日止年度("2019財政年度")減少約人民幣1500萬元,減幅約為60%。
未計非經常性上市開支,集團預期二零二零財政年度的未經審核經調整純利將較二零一九財政年度減少約人民幣1000萬元,減幅約為28%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.